Drug "Aklasta". barashada

Drug "Aklasta" analogues daroogada ( "Veroklast", "Blaztera", "Zolendronat-Teva", iwm) waxay awoodi karaan in ay hoos u dhigi burburinta ah unugyada lafta. Zelendronovaya acid - qayb firfircoon - waxaa ka mid ah fasalka ka mid ah bisphosphonates (walxaha dardaro hortagga lumista lafta).

Drug "Aklasta". description

medicament waxaa soo saaray qaab xal galiyey.

Ka dib markii maamulka xididka, qayb firfircoon waa la qaybiyey unugyada lafta si degdeg ah. Like bisphosphonates kale, zelendronovaya acid waxaa ku kooban inta badan ee meelaha resorption lafta (baabba ').

By ka hortagga burburinta, qayb firfircoon uusan si xun u saameyn kuma guryaha farsamo, habka of formation iyo mineralization lafaha.

Drug "Aklasta". Tilmaamo: maragga

Daawada waxaa loogu lafta cudurka Paget ee (deforming osteitis), osteoporosis postmenopausal (si loo yareeyo suurtagalnimada of jab ku dhabarta, lafta bawdada iyo lafo kale oo kor loogu qaado cufnaanta macdanta ah), si looga hortago oo jab ah lafaha ka dib markii dhaawacyo misigta.

macnihiisu yahay "Aklasta". Waxbarashada: mudada qiyaasta

Ka hor maamulka ka mid ah daroogada loo baahan yahay si loo hubiyo in fuuq si mug leh (robab oo biyo ah) ee u shaqeeyo. Tani waxay si gaar ah muhiim in codsiga ah ee therapy durayo.

Waayo, ka hortagga jab ka dib markii dhaawac sinta ah iyo daaweynta osteoporosis daroogada guide postemenopauznogo "Aklasta" talinaysaa in ay maamusho galiyey xididka sanadkii hal mar in xaddiga shan milligram (hal mar). therapy waa in isku mar qaadan calcium supplements iyo vitamin D.

In daaweynta cudurka Paget ee medicament xididka "Aklasta" talinayaa edbinta jimicsi in qiyaas shan milligram per boqol millilitir oo xal aqueous maamulo sida faleebo hal xididka la isticmaalayo nidaamka. markii Maamulka - oo aan ka yarayn shan iyo toban daqiiqo, xawaaraha waa in uu ahaado joogto ah. Sababo la xaqiiqada ah in cudurka Paget ayaa waxa lagu gartaa burburinta horusocod ah ee lafta, oo dhan bukaanka qaba cudurada this talinayaa qaadashada of dheeraad ah looga baahan yahay maalin walba of vitamin D iyo calcium inta lagu guda jiro tobanka maalmood ee ugu horreeya ka dib markii galiyey.

Maamulka koowaad ee daroogada "Aklasta" sababa muddo dheer ah dembidhaafka osteitis deforming. Waqtigan xaadirka ah, macluumaadka gaarka ah ee dib-u-daweynta cudurka Paget ee aan la heli karin. Si kastaba ha ahaatee, daaweynta sida suurto gal ah, haddii bukaanku leeyahay labakaclaynta. horumarinta Sare ee cudurada ee waxa lagu gartaa sifooyinka soo socda: caadi ma phosphatase xumadoodu ee serum, koror ee dhaqdhaqaaqa ay heerka, iyo jiritaanka calaamadaha caafimaad ee cudurka Paget ee, loo aqoonsaday laba iyo toban bilood ka dib codsiga ah ee dose "Aklasta".

Daawada waxaa laguma talinayo dadka qaba waxqabad kelyaha ee daran.

Dadka waayeelka ah iyo dadka qaba xanuunada beerka sixitaanka qiyaasta loo baahan yahay.

Maqnaanshaha xog ku saabsan nabadgelyada iyo waxtarka ah "Aklasta" daroogada ee bukaanka da'doodu ka yar tahay siddeed iyo toban, waxay daroogada aan la maamulo.

Ka dib markii hordhaca ah ee daroogada tahay si ay u horumariyaan qandho, hargab oo kale syndrome, daal, barar ah ee (naadir), qidmeyntiibulshada, asthenia, qarqaryo. dhibaato soo noq loo tixgeliyaa sida madax xanuun, feejignaan xumo, wareer, neefta oo ku qabata. Mararka qaarkood waxaa lagu calaamadeeyay kartaa paresthesia, syncope, gariirka, somnolence. Bukaanka laga yaabaa in ay dareemaan xanuunka lafaha dhabarta. Waxaa laga yaabaa in horumarinta myalgia, arthralgia, dyspepsia, matag, yalaalugo iyo waxyeelo kale.

Drug waa u inta lagu jiro nuujinta, hypocalcemia, uurka, diidmo.